Works matching DE "MELANOMA immunotherapy"
Results: 101
Targeting the PD-1 pathway: a promising future for the treatment of melanoma.
- Published in:
- Archives of Dermatological Research, 2014, v. 306, n. 6, p. 511, doi. 10.1007/s00403-014-1457-7
- By:
- Publication type:
- Article
American Association of Cancer Research Showcases Immunotherapy Advances.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 4, doi. 10.1093/jnci/djv231
- By:
- Publication type:
- Article
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2015.00649
- By:
- Publication type:
- Article
Immunotherapy in cancer: a combat between tumors and the immune system; you win some, you lose some.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00127
- By:
- Publication type:
- Article
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.
- Published in:
- Pigment Cell & Melanoma Research, 2014, v. 27, n. 3, p. 454, doi. 10.1111/pcmr.12226
- By:
- Publication type:
- Article
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
- Published in:
- Pigment Cell & Melanoma Research, 2013, v. 26, n. 4, p. E8, doi. 10.1111/pcmr.12099
- By:
- Publication type:
- Article
Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-019-56542-4
- By:
- Publication type:
- Article
Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma.
- Published in:
- Histopathology, 2017, v. 70, n. 4, p. 643, doi. 10.1111/his.13070
- By:
- Publication type:
- Article
Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01617
- By:
- Publication type:
- Article
Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01342
- By:
- Publication type:
- Article
Update on use of aldesleukin for treatment of high-risk metastatic melanoma.
- Published in:
- ImmunoTargets & Therapy, 2015, v. 4, p. 79, doi. 10.2147/ITT.S61590
- By:
- Publication type:
- Article
Cancer: Interference identifies immune modulators.
- Published in:
- Nature, 2014, v. 506, n. 7486, p. 39, doi. 10.1038/nature13050
- By:
- Publication type:
- Article
Sizing up a slow assault on cancer.
- Published in:
- Nature, 2013, v. 496, n. 7443, p. 14, doi. 10.1038/496014a
- By:
- Publication type:
- Article
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 6, p. 1143, doi. 10.1002/cam4.1001
- By:
- Publication type:
- Article
Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
- Published in:
- Clinical & Experimental Ophthalmology, 2016, v. 44, n. 6, p. 509, doi. 10.1111/ceo.12688
- By:
- Publication type:
- Article
Dermoscopy of Naevus-associated Melanomas.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 6, p. 671, doi. 10.2340/00015555-2009
- By:
- Publication type:
- Article
Metastatic Melanoma -- A Review of Current and Future Treatment Options.
- Published in:
- Acta Dermato-Venereologica, 2015, v. 95, n. 5, p. 516, doi. 10.2340/00015555-2035
- By:
- Publication type:
- Article
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4339, doi. 10.2147/OTT.S136194
- By:
- Publication type:
- Article
Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single‐centre analysis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2018, v. 32, n. 6, p. 972, doi. 10.1111/jdv.14629
- By:
- Publication type:
- Article
Advances in immunotherapy for melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immune responsiveness in a mouse model of combined adoptive immunotherapy with NK and dendritic cells.
- Published in:
- Journal of Cancer Research & Therapeutics, 2013, v. 9, p. S160, doi. 10.4103/0973-1482.122516
- By:
- Publication type:
- Article
Organ conservation approach for primary mucosal malignant melanoma of the larynx.
- Published in:
- 2013
- By:
- Publication type:
- Letter to the Editor
Bone Marrow Dendritic Cells Derived Microvesicles for Combinational Immunochemotherapy against Tumor.
- Published in:
- Advanced Functional Materials, 2017, v. 27, n. 42, p. n/a, doi. 10.1002/adfm.201703191
- By:
- Publication type:
- Article
Title of presented paper: The role of monoclonal antibodies in melanoma immunotherapy.
- Published in:
- European Journal of Clinical & Experimental Medicine, 2023, p. 121
- By:
- Publication type:
- Article
PD-1 and PD-L1 Inhibition in the Treatment of Advanced Melanoma.
- Published in:
- Journal of OncoPathology, 2013, v. 1, n. 4, p. 83, doi. 10.13032/tjop.2052-5931.100066
- By:
- Publication type:
- Article
Quantitative Characterization of the Exposure-Response Relationship for Cancer Immunotherapy: A Case Study of Nivolumab in Patients With Advanced Melanoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With Melanoma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 1, p. 5, doi. 10.1002/psp4.12131
- By:
- Publication type:
- Article
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.
- Published in:
- Stem Cells International, 2015, p. 1, doi. 10.1155/2016/8394960
- By:
- Publication type:
- Article
Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150751
- By:
- Publication type:
- Article
Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140744
- By:
- Publication type:
- Article
Immunotherapy in Metastatic Melanoma: Better Alone or in Combination?
- Published in:
- Cancer & Chemotherapy Reviews, 2016, v. 11, n. 2, p. 39
- By:
- Publication type:
- Article
Somatic driver mutations in melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Molecular insights into melanoma brain metastases.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interaction of molecular alterations with immune response in melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Immune and molecular correlates in melanoma treated with immune checkpoint blockade.
- Published in:
- 2017
- By:
- Publication type:
- journal article
New immunotherapies show promise in some patients: Physicians try to balance optimism with realistic expectations.
- Published in:
- 2015
- By:
- Publication type:
- Other
Highlights from the AACR annual meeting.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
Ipilimumab before BRAF inhibitor treatment may be more beneficial than vice versa for the majority of patients with advanced melanoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 11, p. 1695, doi. 10.1002/cncr.28620
- By:
- Publication type:
- Article
Intratumoral CD4<sup>+</sup> T Lymphodepletion Sensitizes Poorly Immunogenic Melanomas to Immunotherapy with an OX40 Agonist.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 7, p. 1884, doi. 10.1038/jid.2014.42
- By:
- Publication type:
- Article
Hippo: Hungry, Hungry for Melanoma Invasion.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 1, p. 14, doi. 10.1038/jid.2013.372
- By:
- Publication type:
- Article
What's new in 2018 regarding melanoma staging and surgery?
- Published in:
- Oncolog-Hematolog, 2018, n. 43, p. 47
- By:
- Publication type:
- Article
Melanoma Immunotherapy: Next-Generation Biomarkers.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00178
- By:
- Publication type:
- Article
Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00061
- By:
- Publication type:
- Article
Melanoma therapy with transdermal mitoxantrone cubic phases.
- Published in:
- Drug Delivery, 2016, v. 23, n. 5, p. 1565, doi. 10.3109/10717544.2015.1024898
- By:
- Publication type:
- Article
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.
- Published in:
- Cancer Gene Therapy, 2014, v. 21, n. 8, p. 349, doi. 10.1038/cgt.2014.35
- By:
- Publication type:
- Article
Combining forces: the promise and peril of synergistic immune checkpoint blockade and targeted therapy in metastatic melanoma.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 43, doi. 10.1007/s10555-017-9656-2
- By:
- Publication type:
- Article
BRAF plus MEK-targeted drugs: a new standard of treatment for BRAF-mutant advanced melanoma.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 35, doi. 10.1007/s10555-017-9660-6
- By:
- Publication type:
- Article
Metastatic melanoma: how research can modify the course of a disease.
- Published in:
- Cancer & Metastasis Reviews, 2017, v. 36, n. 1, p. 3, doi. 10.1007/s10555-017-9664-2
- By:
- Publication type:
- Article
Immunotherapy of melanoma: Present options and future promises.
- Published in:
- Cancer & Metastasis Reviews, 2015, v. 34, n. 1, p. 115, doi. 10.1007/s10555-014-9542-0
- By:
- Publication type:
- Article